Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,255 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Impact of a combined treatment of angiotensin II type 1 receptor blockade and 3-hydroxy-3-methyl-glutaryl-CoA-reductase inhibition on secretory phospholipase A2-type IIA and low density lipoprotein oxidation in patients with coronary artery disease.
Divchev D, Grothusen C, Luchtefeld M, Thoenes M, Onono F, Koch R, Drexler H, Schieffer B. Divchev D, et al. Among authors: drexler h. Eur Heart J. 2008 Aug;29(16):1956-65. doi: 10.1093/eurheartj/ehn276. Epub 2008 Jun 18. Eur Heart J. 2008. PMID: 18565968 Clinical Trial.
Cell-based therapy for heart failure.
Wollert KC, Drexler H. Wollert KC, et al. Among authors: drexler h. Curr Opin Cardiol. 2006 May;21(3):234-9. doi: 10.1097/01.hco.0000221586.94490.d2. Curr Opin Cardiol. 2006. PMID: 16601463 Review.
Transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Procedural and follow-up results after implantation of the Starflex occluder device with conjunctive intensified anticoagulation regimen.
Fischer D, Fuchs M, Schaefer A, Schieffer B, Jategaonkar S, Hornig B, Drexler H, Meyer GP. Fischer D, et al. Among authors: drexler h. J Interv Cardiol. 2008 Apr;21(2):183-9. doi: 10.1111/j.1540-8183.2008.00345.x. Epub 2008 Feb 25. J Interv Cardiol. 2008. PMID: 18312307 Free article.
Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: role of beta-catenin transduction and cell dose.
Templin C, Kotlarz D, Faulhaber J, Schnabel S, Grote K, Salguero G, Luchtefeld M, Hiller KH, Jakob P, Naim HY, Schieffer B, Hilfiker-Kleiner D, Landmesser U, Limbourg FP, Drexler H. Templin C, et al. Among authors: drexler h. J Mol Cell Cardiol. 2008 Sep;45(3):394-403. doi: 10.1016/j.yjmcc.2008.06.010. Epub 2008 Jul 11. J Mol Cell Cardiol. 2008. PMID: 18671980 Free article.
Conditional transgenic expression of fibroblast growth factor 9 in the adult mouse heart reduces heart failure mortality after myocardial infarction.
Korf-Klingebiel M, Kempf T, Schlüter KD, Willenbockel C, Brod T, Heineke J, Schmidt VJ, Jantzen F, Brandes RP, Sugden PH, Drexler H, Molkentin JD, Wollert KC. Korf-Klingebiel M, et al. Among authors: drexler h. Circulation. 2011 Feb 8;123(5):504-14. doi: 10.1161/CIRCULATIONAHA.110.989665. Epub 2011 Jan 24. Circulation. 2011. PMID: 21262993 Free article.
Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study.
Kempf T, Sinning JM, Quint A, Bickel C, Sinning C, Wild PS, Schnabel R, Lubos E, Rupprecht HJ, Münzel T, Drexler H, Blankenberg S, Wollert KC. Kempf T, et al. Among authors: drexler h. Circ Cardiovasc Genet. 2009 Jun;2(3):286-92. doi: 10.1161/CIRCGENETICS.108.824870. Epub 2009 Mar 31. Circ Cardiovasc Genet. 2009. PMID: 20031597
1,255 results